Cancer Moonshot Report Describes Initial Success, Remaining Challenges

The Cancer Moonshot initiative has been successful in drawing private-sector partners for improving data-sharing among researchers, but the project has yet to mature.

Written byBen Andrew Henry
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, MARC NOZELL

The White House issued a report Monday (October 18) on the progress of US Vice President Joe Biden’s Cancer Moonshot initiative, an ambitious effort to accelerate cancer research. The report lays out broad goals for the initiative over the next two years, including supporting innovation, establishing private-sector partnerships, and fostering collaboration.

Congress has yet to approve $700 million of the project’s $1 billion budget, Reuters reports.

Among its accomplishments so far, the Cancer Moonshot has secured a partnership between the National Cancer Institute, Amazon, and Microsoft to provide cloud-based data-sharing for cancer researchers, according to a White House press release. It has also struck deals with ride-sharing services Uber and Lyft to provide affordable transportation for cancer patients to and from treatment.

Under the initiative, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies